A tri-specific antibody engages T and myeloid cells to augment anti-tumor immunity
RNA-seq (gene expression) · human · 25 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 25 samples: 9 × Tri-TCE vs 8 × control vs 8 × BiTEGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunityNature biomedical engineering · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE281102_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1182282 and SRA study SRP543252. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 25 samples.
How we read this: 3 replicated groups read from 25 sample titles; they account for 25 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8610881 control-345 control
- GSM8610882 control-642 control
- GSM8610883 control-384 control
- GSM8610884 control-360 control
- GSM8610885 control-361 control
- GSM8610886 control-349 control
- GSM8610887 control-343 control
- GSM8610888 control-390 control
- GSM8610889 BiTE-391 BiTE
- GSM8610890 BiTE-348 BiTE
- GSM8610891 BiTE-353 BiTE
- GSM8610892 BiTE-358 BiTE
- GSM8610893 BiTE-376 BiTE
- GSM8610894 BiTE-379 BiTE
- GSM8610895 BiTE-389 BiTE
- GSM8610896 BiTE-928 BiTE
- GSM8610897 Tri-TCE-362 Tri-TCE
- GSM8610898 Tri-TCE-363 Tri-TCE
- GSM8610899 Tri-TCE-352 Tri-TCE
- GSM8610900 Tri-TCE-346 Tri-TCE
- GSM8610901 Tri-TCE-347 Tri-TCE
- GSM8610902 Tri-TCE-378 Tri-TCE
- GSM8610903 Tri-TCE-926 Tri-TCE
- GSM8610904 Tri-TCE-367 Tri-TCE
- GSM8610905 Tri-TCE-368 Tri-TCE
- GSE281351 RNA sensing induced by chromosome missegregation augments anti-tumor immunity V 16 samples shares anti-tumor, immunity, augment
- GSE281348 RNA sensing induced by chromosome missegregation augments anti-tumor immunity II 12 samples shares anti-tumor, immunity, augment
- GSE295277 Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity [Human_Mulitome_Cohort1] 14 samples shares anti-tumor, immunity, myeloid
- GSE313035 METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin 67 samples shares anti-tumor, immunity
- GSE271543 UCPVax, a CD4 helper peptide vaccine induces polyfunctional Th1 cells, antibody response and epitope spreading to improve antitumor immunity [scRNA-seq] 5 samples shares antibody, immunity
- GSE275892 Depletion of RNA-editing enzyme ADAR1 invigorates NK cells anti-tumor immunity 4 samples shares anti-tumor, immunity
- GSE301351 The single-cell transcriptome defines an effector Vd1 gd T cell-dependent anti-tumor immunity in human gastrointestinal stromal tumor (GIST) [10X] 6 samples shares anti-tumor, immunity
- GSE313850 RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity [CUT&Tag-seq] 44 samples shares anti-tumor, immunity
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.